Have they resolved supply chain issues? Based on the most recent Q they might have or mostly have right? That is how you prepare for demand and ramp up. That is how you come out with all guns blazing against the obstacles. I still say that the potential buildout at Sawston can be and likely is now being used as leverage in negotiations with potential partners. Just the threat of “going big” there likely puts shivers down the spines of execs and analysts alike with what we now know about the new route of administration of checkpoint inhibitors being less safe ie more lethal. By the time Flaskworks is ready to ramp up next year big pharma will have of necessity made much bigger moves than just suspending early research projects for their self preservation with regard to oncology treatment departments. Best wishes.
Market Data 
Markets 
AI
